Classifications

• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
  • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
  • C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
  • C08F20/52—Amides or imides
  • C08F20/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K6/00—Preparations for dentistry
  • A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
  • A61K6/65—Dyes
  • A61K6/68—Thermochromic dyes
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K6/00—Preparations for dentistry
  • A61K6/70—Preparations for dentistry comprising inorganic additives
  • A61K6/78—Pigments
• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
  • C08F8/00—Chemical modification by after-treatment
• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
  • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
  • C08F2800/20—Copolymer characterised by the proportions of the comonomers expressed as weight or mass percentages
• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
  • C08F2810/00—Chemical modification of a polymer
  • C08F2810/20—Chemical modification of a polymer leading to a crosslinking, either explicitly or inherently
• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
  • C08F2810/00—Chemical modification of a polymer
  • C08F2810/40—Chemical modification of a polymer taking place solely at one end or both ends of the polymer backbone, i.e. not in the side or lateral chains

Definitions

• AMIDE-FUNCTIONAL POLYMERS COMPOSITIONS, AND METHODS
• Thermally reversible gel compositions including a thermally responsive viscosity modifier are useful for applications in environments where the temperature is generally higher than the ambient or pre-treatment temperature of the composition. Such compositions can be of low viscosity at ambient temperature, but substantially increase in viscosity or thicken to a thickened, semi-solid, or gel-like composition in the higher temperature environment (e.g., an oral environment).
• Known thermally reversible compositions include, for example, a poly(oxyalkylene) as a thermally responsive viscosity modifier. What is needed are non-poly(oxyalkylene)-based polymers that may preferably be useful as thermally responsive viscosity modifiers in thermally responsive compositions.
• the present invention provides a reactive polymer including a non-terminal monomeric unit including a pendant ethylenically unsaturated group and monomeric units derived from N-isopropylacrylamide (e.g., polymerized or copolymerized N-isopropylacrylamide).
• the pendant ethylenically unsaturated group includes a (meth)acrylate group.
• the present invention provides a reactive polymer including a polymeric backbone having at least tliree ethylenically unsaturated pendant groups and a plurality of pendant groups of the formula -C(O)NHCH(CH 3 ) 2 attached to the backbone.
• the pendant ethylenically unsaturated group includes a (meth)acrylate group.
• the present invention provides a method of preparing a reactive polymer.
• the method includes: copolymerizing monomers including N- isopropylacrylamide and a hydroxy-functional (meth)acrylate monomer to form a hydroxy-functional polymer; and reacting the hydroxy-functional polymer with a hydroxy-reactive material selected from the group consisting of a (meth)acrylate- functional isocyanate, a (meth)acrylate-functional epoxide, a vinyl azlactone, and combinations thereof.
• the monomers further include acrylamide.
• the present invention provides a method of preparing a reactive polymer.
• the method includes: copolymerizing monomers including N- isopropylacrylamide and vinyl azlactone to form an azlactone-functional polymer; and reacting the azlactone-functional polymer with a hydroxy- functional (meth)acrylate.
• the present invention provides a dental composition suitable for use in the oral environment.
• the dental composition includes: a polymer including monomeric units derived from N-isopropylacrylamide (e.g., polymerized or copolymerized N-isopropylacrylamide); and a dental additive.
• the dental composition is in the form of a dispersion, suspension, emulsion, or solution.
• the dental composition is an aqueous composition.
• the dental composition is thermally responsive.
• the dental composition further includes a polymerizable component.
• the present invention provides a composition including: a reactive polymer including a non-terminal monomeric unit including a pendant ethylenically unsaturated group and monomeric units derived from N- isopropylacrylamide (e.g., polymerized or copolymerized N- isopropylacrylamide); and water.
• a reactive polymer including a non-terminal monomeric unit including a pendant ethylenically unsaturated group and monomeric units derived from N- isopropylacrylamide (e.g., polymerized or copolymerized N- isopropylacrylamide); and water.
• the composition is thermally responsive.
• the present invention provides a method of treating an oral surface.
• the method includes: applying a thermally responsive composition in a low viscosity state at a pre-treatment temperature to the oral surface, the composition including water and a polymer including monomeric units derived from N-isopropylacrylamide (e.g., polymerized or copolymerized N- isopropylacrylamide); and allowing the composition to warm to a treatment temperature and exhibit a thermal response.
• applying the composition includes delivering the composition through an orifice, preferably the orifice of a syringe.
• applying the composition includes painting the composition, brushing the composition, syringing the composition, misting the composition, spraying the composition, applying a substrate having the composition thereon, or combinations thereof.
• the present invention provides a method of hardening a composition on a surface.
• the method includes: applying a thermally responsive composition in a low viscosity state at a pre-treatment temperature to the surface, the composition including water and a reactive thermally responsive viscosity modifier including a polymer including a non-terminal monomeric unit including a pendant ethylenically unsaturated group and monomeric units derived from N- isopropylacrylamide (e.g., polymerized or copolymerized N- isopropylacrylamide); allowing the composition to warm to a treatment temperature and exhibit a thermal response; and inducing the reactive thermally responsive viscosity modifier to react.
• a reactive thermally responsive viscosity modifier including a polymer including a non-terminal monomeric unit including a pendant ethylenically unsaturated group and monomeric units derived from N- isopropylacrylamide (e.g., polymerized or copolymerized N- isopropy
• the present invention provides a thermally responsive composition including: a polymer including monomeric units derived from N- isopropylacrylamide (e.g., polymerized or copolymerized N- isopropylacrylamide); a polymerizable component different than the polymer; and water.
• the present invention provides a method of preparing a hardened composition on a surface. The method includes: applying a thermally responsive composition in a low viscosity state at a pre-treatment temperature to the surface, allowing the composition to warm to a treatment temperature; and inducing the polymerizable component to polymerize.
• the thermally responsive composition includes: a polymer including monomeric units derived from N- isopropylacrylamide (e.g., polymerized or copolymerized N- isopropylacrylamide); a polymerizable component different than the polymer; and water.
• a polymer including monomeric units derived from N- isopropylacrylamide e.g., polymerized or copolymerized N- isopropylacrylamide
• a polymerizable component different than the polymer e.g., water.
• compositions and methods of the present invention provide hardenable compositions (e.g., hardenable gels).
• Hardenable compositions can offer advantages over unhardenable compositions (e.g., thermally reversible compositions).
• Advantages after hardening may include, for example, dimensional stability, thermal stability, improved stability to liquids, improved adhesion, and the potential for sustained release of incorporated additives (e.g., dental additives).
• thermally responsive refers to the occurrence of a change in a physical property in response to a change in temperature.
• thermally responsive viscosity modifier means a material that may be incorporated into a composition to provide the composition the capability of substantially changing in viscosity (including a phase change, e.g., a single liquid phase to separate into separate liquid-liquid phases or liquid- solid phases) in response to a change in temperature.
• a "reactive" thermally responsive viscosity modifier is a thermally responsive viscosity modifier that includes a reactive group.
• a "reactive” group is a group that can react under selected conditions (e.g., in the presence of free radicals or under condensation reaction conditions) with another reactive group or another component (e.g., a crosslmker or a compound with condensation reaction sites).
• the reactive group can react with another reactive group and/or another component to form crosslinks through dimerization, oligomerization, and/or polymerization reactions.
• polymer is used to encompass homopolymers (e.g., polymers derived from a single monomer) and copolymers (e.g., polymers derived from two or more different monomers).
• pendant refers to groups that are attached to the polymer backbone.
• hardenable refers to a material that can be “hardened.” As used herein, “harden” is meant to encompass processes including, for example, crosslinking, dimerization, oligomerization, and/or polymerization reactions.
• (meth)acryl is an abbreviation intended to refer collectively to “acryl” and/or “methacryl.”
• a “at least one,” and “one or more” are used interchangeably.
• a dental composition suitable for use in the oral environment includes a polymer including monomeric units derived from N-isopropylacrylamide (e.g., polymerized or copolymerized N-isopropylacrylamide, as described in detail herein below) and a dental additive.
• the dental composition optionally includes a polymerizable component.
• the composition is thermally responsive.
• the composition is in the form of a dispersion, suspension, emulsion, or solution.
• the composition is an aqueous composition.
• a reactive polymer in another aspect of the present invention, includes a pendant ethylenically unsaturated group and monomeric units derived from N-isopropylacrylamide (e.g., polymerized or copolymerized N-isopropylacrylamide).
• the reactive polymer includes a polymeric backbone having at least three ethylenically unsaturated pendant groups and a plurality of pendant groups of the formula -C(O)NHCH(CH 3 ) 2 attached to the backbone.
• the reactive polymers in combination with water form thermally responsive compositions.
• the thermally responsive compositions are dental compositions suitable for use in the oral environment.
• a thermally responsive composition is generally provided in a low viscosity state at a pre-treatment temperature prior to application onto a target site (e.g., a surface of a body), but typically becomes highly viscous (e.g., thick, and controllable) or forms a film or coating (e.g., flexible or rigid) at the target site.
• a target site e.g., a surface of a body
• highly viscous e.g., thick, and controllable
• the composition may optionally be hardened to provide a semi-permanent or permanent composition.
• the composition typically has a low viscosity (e.g., a free- flowing fluid state) initially at a pre-treatment temperature, it generally requires, for example, lower syringe extrusion forces to deliver the composition to the intended site.
• the low viscosity compositions can provide the ability to spray a fine mist or aerosol to a relatively large surface area (e.g., an oral cavity), typically allowing subsequent long term retention upon gellation or phase separation on the warm target site. This can allow the user the freedom to select a dispenser or applicator from an array of systems that are incapable of delivering high viscosity materials.
• production of low viscosity compositions may allow for easier processing and greater uniformity and consistency.
• Thermally responsive compositions are generally suitable for use in or on living tissues where a composition having a pre-treatment temperature at or lower than ambient (e.g., room temperature) is applied to hard and/or soft tissue that is near or at oral temperature (e.g., 30°C to 39°C).
• ambient e.g., room temperature
• oral temperature e.g., 30°C to 39°C
• a thermally responsive composition in vivo can provide materials that exhibit enhanced physical properties and the advantage of not reverting to a fluid state upon cooling or simple aqueous dilution. Moreover, many of the problems of formulation, handling, delivery, and application of viscous compositions maybe overcome, since the compositions of the present invention may be free-flowing liquids prior to treatment.
• the initial viscosity of the unhardened composition at the pretreatment temperature may be low enough such that the composition is in a liquid state.
• treatment temperature e.g., a temperature at or near oral temperature
• the viscosity can increase to thicken the composition.
• a viscosity increase in the range of 5-fold, 10-fold, or even 100-fold or more can be experienced when the initial viscosity is such that the composition is a liquid.
• a composition in a liquid state may have a viscosity of 0-7000 poise.
• the viscosity of the composition can increase to at least 10,000 poise.
• the unhardened composition Upon lowering the temperature, the unhardened composition preferably has the ability to reverse its viscosity and return to the flow properties of a liquid.
• the thermally responsive composition may separate into phases, resulting, for example, in the formation of a precipitate or a film.
• the pre-treatment temperature is the temperature at which the composition is subjected to prior to application or treatment.
• the pretreatment temperature is preferably at least 5°C and more preferably at least 20°C.
• the pretreatment temperature is preferably at most 29°C and more preferably at most 25°C. However, there may be certain instances where the temperature may be outside this range.
• a pre-treatment temperature of at least 20°C allows the composition to be easily stored at ambient or room temperature.
• a pre-treatment temperature of at most 25°C allows the composition to be easily stored at ambient or room temperature.
• the compositions of the invention can also be stored at lower, refrigerated pre-treatment temperatures of 5°C to 10°C to provide improved stability and shelf life.
• a refrigerated pretreatment temperature is at least 5°C.
• a refrigerated pretreatment temperature is at most 10°C.
• the treatment temperature is the temperature at which the composition is exposed to during application.
• the treatment temperature can be at or near body temperature.
• the treatment temperature is at least 30°C.
• the treatment temperature is at most 39°C.
• compositions of the present invention optionally include a reactive polymer.
• the reactive polymer includes a non-terminal monomeric unit including a pendant ethylenically unsaturated group and monomeric units derived from N-isopropylacrylamide (e.g., polymerized or copolymerized N- isopropylacrylamide).
• Compositions of the present invention preferably include at least 1% by weight of the reactive polymer and more preferably at least 10% by weight of the reactive polymer, based on the total weight of the composition.
• Compositions of the present invention preferably include at most 99% by weight of the reactive polymer and more preferably at most 90% by weight of the reactive polymer, based on the total weight of the composition.
• compositions of the present invention preferably include at least 30% by weight of water, and more preferably at least 40% by weight of water, based on the total weight of the composition. In some embodiments, compositions of the present invention preferably include at most 90%) by weight of water, and more preferably at most 80% by weight of water, based on the total weight of the composition.
• Water is preferably purified by methods including, for example, distillation, filtration, and ion-exchange processes, h addition to water, compositions of the present invention may optionally include a solvent.
• Useful solvents include, for example, polyols (e.g., propylene glycol, poly(ethylene glycol), and glycerin).
• the solvent is a water miscible solvent.
• compositions of the present invention may be prepared as a single part liquid or gel by combining the above components.
• the polymer and any additional components may be mixed at the desired temperature (e.g., room temperature).
• compositions of the present invention may be prepared as multiple part liquids and/or gels that are mixed prior to delivery to the tissue.
• Such multiple part systems may provide shelf stability that may not exist in single part compositions including, for example, compositions including an initiator system based on two-component redox chemistry, and compositions including an additive that is incompatible with other materials in the composition.
• polymers that include monomeric units derived from N- isopropylacrylamide can be prepared by any suitable method known to one of skill in the art. Such methods include, for example, those disclosed in the Examples.
• polymers that include monomeric units derived from N- isopropylacrylamide can be prepared by homopolymerizing or copolymerizing N-isopropylacrylamide.
• Polymers that include monomeric units derived from N- isopropylacrylamide preferably include at least 1 mole %, more preferably at least 50 mole %, and most preferably at least 70 mole % of monomeric units derived from N-isopropylacrylamide, based on the total moles of monomeric units.
• Suitable monomers to copolymerize with N-isopropylacrylamide may be selected by one skilled in the art to provide useful polymers.
• Exemplary monomers that may be used in copolymerizations include, for example, acrylic acid, methacryhc acid, itaconic acid, N- vinyl pyrrohdone, n-butyl acrylate, isobutyl acrylate, lauryl acrylate, octadecyl acrylate, 3-(trimethoxysilyl)propyl methacrylate, macromers (e.g., silicone macromers, fluorocarbon macromers, hydrocarbon macromers), trimethylammoniumethyl methacrylate tetrafluoroborate, dimethylhexadecylammoniumethyl methacrylate bromide, 2- (methyl(nonafluorobutyl)sulfonyl)amino)ethyl acrylate, 2- (methyl(nonafluorobutyl)
• the present invention provides a reactive polymer including a non-terminal monomeric unit including a pendant ethylenically unsaturated group and monomeric units derived from N-isopropylacrylamide (e.g., polymerized or copolymerized N-isopropylacrylamide).
• the present invention provides a polymer including a polymeric backbone having at least three ethylenically unsaturated pendant groups and a plurality of pendant groups of the formula -C(O)NHCH(CH 3 ) 2 attached to the backbone.
• Reactive polymers including an ethylenically unsaturated group can react, for example, in the presence of free radicals to form crosslinks through dimerization, oligomerization, and/or polymerization reactions.
• the non-terminal monomeric unit including a pendant ethylenically unsaturated group and/or the plurality of pendant groups of the formula -C(O)NHCH(CH ) attached to the backbone may be derived, for example, from (meth)acrylate monomers.
• the reactive polymer can be prepared by copolymerizing monomers including N-isopropylacrylamide and a hydroxy- functional (meth)acrylate monomer to form a hydroxy-functional copolymer. Methods for copolymerizing such monomers are well known to one of skill in the art. Illustrative conditions for copolymerizing N-isopropylacrylamide are disclosed in the Examples.
• the hydroxy-functional copolymer can further be reacted with hydroxy- reactive materials including, for example, (meth)acrylate-functional isocyanates, (meth)acrylate-functional epoxides, vinyl azlactones, and combinations thereof, to provide a (meth)acrylate-functional polymer.
• hydroxy- reactive materials including, for example, (meth)acrylate-functional isocyanates, (meth)acrylate-functional epoxides, vinyl azlactones, and combinations thereof, to provide a (meth)acrylate-functional polymer.
• hydroxy-reactive material preferably at least 0.01 equivalents of hydroxy-reactive material, more preferably at least 0.1 equivalents of hydroxy-reactive material, and most preferably at least 0.2 equivalents of hydroxy-reactive material, per one equivalent of hydroxy in the hydroxy-functional polymer, is mixed with the hydroxy-functional polymer.
• hydroxy-reactive material preferably at most 2 equivalents of hydroxy-reactive material, more preferably at most 1 equivalent of hydroxy-reactive material, and most preferably at most 0.8 equivalents of hydroxy-reactive material, per one equivalent of hydroxy in the hydroxy-functional polymer, is mixed with the hydroxy-functional polymer.
• Preferred (meth)acrylate-functional isocyanates include, for example, 2- isocyanatoethyl methacrylate. Methods for reacting such compounds are well known to one of skill in the art. Illustrative conditions for reacting a
• Preferred (meth)acrylate-functional epoxides include, for example, glycidyl methacrylate. Methods for reacting such compounds are well known to one of skill in the art.
• Preferred vinyl azlactones include, for example, 4,4-dimethyl-2-vinyl-2- oxazolin-5-one. Methods for reacting such compounds are well known to one of skill in the art. Illustrative conditions for reacting a vinyl azlactone with a hydroxy-functional polymer are disclosed in the Examples. In another illustrative method, the reactive polymer can be prepared by copolymerizing monomers including N-isopropylacrylamide and a vinyl azlactone to form an azlactone-functional polymer. Methods for copolymerizing such monomers are well known to one of skill in the art. Illustrative conditions for copolymerizing the monomers are described in the Examples.
• the azlactone-functional polymer can further be reacted with a hydroxy- functional (meth)acrylate to provide a (meth)acrylate-functional polymer.
• a hydroxy-functional (meth)acrylate preferably at least 0.01 equivalents of hydroxy-functional (meth)acrylate, more preferably at least 0.1 equivalents of hydroxy-functional (meth)acrylate, and most preferably at least 0.2 equivalents of hydroxy- functional (meth)acrylate, per one equivalent of azlactone in the azlactone- functional polymer, is mixed with the azlactone-functional polymer.
• hydroxy-functional (meth)acrylate For the reaction, preferably, at most 2 equivalents of hydroxy-functional (meth)acrylate, more preferably at most 1 equivalent of hydroxy-functional (meth)acrylate, and most preferably at most 0.8 equivalents of hydroxy-functional (meth)acrylate, per one equivalent of azlactone in the azlactone-functional polymer, is mixed with the azlactone-functional polymer.
• Preferred hydroxy-functional (meth)acrylates include, for example, 2- hydroxyethyl methacrylate. Methods for reacting such compounds are well known to one of skill in the art. Illustrative conditions for reacting a hydroxy- functional (meth)acrylate with an azlactone-functional polymer are disclosed in the Examples.
• Reactive polymers preferably include at least 1 mole %, more preferably at least 50 mole %, and most preferably at least 70 mole % of monomeric units derived from N-isopropylacrylamide, based on the total moles of monomeric units.
• Reactive polymers preferably include at most 99 mole %, more preferably at most 95 mole %, and most preferably at most 90 mole % of monomeric units derived from N-isopropylacrylamide, based on the total moles of monomeric units.
• Reactive polymers preferably include at least 1 mole %, more preferably at least 5 mole %>, and most preferably at least 10 mole % of non-terminal monomeric units comprising a pendant ethylenically unsaturated group, based on the total moles of monomeric units.
• Reactive polymers preferably include at most 90 mole %, more preferably at most 50 mole %, and most preferably at most 30 mole % of non-terminal monomeric units comprising a pendant ethylenically unsaturated group, based on the total moles of monomeric units.
• Other monomers that may be used in the copolymerization include, for example, those disclosed in the Examples.
• compositions of the present invention that include a reactive polymer and/or a polymerizable component preferably also include an initiator system (e.g., one or more initiators) or catalyst that enables the composition to be hardened.
• an initiator system e.g., one or more initiators
• visible and/or near-infrared photoinitiator systems may be used to initiate photopolymerization in compositions including free-radically polymerizable components.
• a monomer can be combined with a three component or ternary photoinitiator system including a sensitizer, an electron donor, and an iodonium salt as disclosed, for example, in U.S. Pat. No. 5,545,676 (Palazzotto et al.).
• the composition may include a binary initiator system including a sensitizer (e.g., camphorquinone) and an electron donor (e.g., a secondary or a tertiary alkyl amine compound as disclosed, for example, in U.S. Pat. No. 4,071,424 (Dart et al.)).
• a sensitizer e.g., camphorquinone
• an electron donor e.g., a secondary or a tertiary alkyl amine compound as disclosed, for example, in U.S. Pat. No. 4,071,424 (Dart et al.)
• acylphosphine oxides useful in the invention are those in which the R and R 1 groups are phenyl or lower alkyl- or lower alkoxy-substituted phenyl.
• lower alkyl and “lower alkoxy” is meant such groups having from 1 to 4 carbon atoms.
• the acylphosphine oxide is bis(2,4,6- trimethylbenzoyl)phenyl phosphine oxide available under the trade designation IRGACURE 819 from Ciba Specialty Chemicals (Tarrytown, NY).
• redox catalysts including oxidants and reductants for inducing free radical polymerization in multi-component systems is also useful for generating hardened gels.
• a preferred mode of initiating the polymerization reaction uses oxidizing and reducing agents as a redox catalyst system.
• oxidizing and reducing agents as a redox catalyst system.
• Various redox systems optionally including microencapsulated reducing and/or oxidizing agents are disclosed in U.S. Pat. No. 5,154,762 (Mitra et al).
• the oxidizing agent reacts with or otherwise cooperates with the reducing agent to produce free radicals.
• the free radicals are capable of initiating polymerization of the ethylenically unsaturated moiety.
• the oxidizing and reducing agents preferably are sufficiently soluble and are present in an amount sufficient to permit an adequate free radical reaction rate as disclosed in U.S. Pat. No. 6,136,885 (Rusin et al.).
• a preferred class of oxidizing agents includes persulfates (e.g., sodium, potassium, ammonium, and alkyl ammonium persulfates).
• oxidizing agents includes peroxides or peroxide salts (e.g., hydrogen peroxide, benzoyl peroxide, and hydroperoxides including, for example cumene hydroperoxide, tert-butyl hydroperoxide, tert-amyl hydroperoxide, and 2,5- dihydroperoxy-2,5-dimethylhexane).
• peroxides or peroxide salts e.g., hydrogen peroxide, benzoyl peroxide, and hydroperoxides including, for example cumene hydroperoxide, tert-butyl hydroperoxide, tert-amyl hydroperoxide, and 2,5- dihydroperoxy-2,5-dimethylhexane.
• Other preferred oxidizing agents include salts of cobalt (III) and iron (III), perboric acid and its salts, and salts of a permanganate anion. Combinations of any of the above mentioned oxidizing agents can also be used.
• Preferred reducing agents include, for example, amines (e.g., aromatic amines), ascorbic acid, metal complexed ascorbic acid, cobalt (II) chloride, ferrous chloride, ferrous sulfate, hydrazine, hydroxylamine, oxalic acid, thiourea, and salts of dithionite, thiosulfate, benzene sulfinate, or sulfite anions.
• amines e.g., aromatic amines
• metal complexed ascorbic acid metal complexed ascorbic acid
• cobalt (II) chloride ferrous chloride
• ferrous sulfate ferrous sulfate
• hydrazine hydroxylamine
• oxalic acid thiourea
• salts of dithionite, thiosulfate, benzene sulfinate, or sulfite anions include, for example, amines (
• compositions of the present invention preferably include at least O.OP/o by weight of the initiator and more preferably at least 0.1 % by weight of the initiator, based on the total weight of the composition. If initiators are included in compositions of the present invention, the compositions preferably include at most 10%o by weight of the initiator and more preferably at most 5% by weight of the initiator, based on the total weight of the composition.
• compositions of the present invention may optionally include a polymerizable component different than the reactive polymer (e.g., a secondary polymerizable component). If a polymerizable component different than the reactive polymer is included, the composition preferably includes at least 1% > by weight of the polymerizable component and more preferably at least 5% by weight of the polymerizable component, based on the total weight of the composition. If a polymerizable component different than the reactive polymer is included, the composition preferably includes at most 90% > by weight of the polymerizable component and more preferably at most 80% by weight of the polymerizable component, based on the total weight of the composition.
• the compositions are photopolymerizable, i.e., the compositions include a polymerizable component and a photoinitiator (i.e., a photoinitiator system) that upon irradiation with actinic radiation initiates the polymerization (or hardening) of the composition.
• a photoinitiator i.e., a photoinitiator system
• Such photopolymerizable compositions are preferably free radically polymerizable.
• the compositions are chemically polymerizable, i.e., the compositions contain a chemical initiator system that can polymerize, cure, or otherwise harden the composition without dependence on irradiation with actinic radiation.
• chemically polymerizable compositions are sometimes referred to as "self-cure" compositions and may include, for example, glass ionomer cements (e.g., conventional and resin-modified glass ionomer cements), redox cure systems, silane moieties capable of undergoing a condensation reaction (as described, for example, in U.S. Pat. Nos.
• Ethylenically Unsaturated Compounds include, for example, polymerizable monomers, polymerizable oligomers, polymerizable polymers, and combinations thereof.
• the polymerizable component is free radically polymerizable.
• Preferred monomers, oligomers, and polymers are those which are partially or fully water miscible.
• Suitable polymerizable monomers and oligomers include, for example, poly(ethyleneglycol) dimethacrylate (PEGDMA), tetrahydrofurfural methacrylate, as well as hydroxylic functional monomers including, for example, 2-hydroxyethyl methacrylate (HEMA), glycidyl dimethacrylate (GDMA), and glycidyl monomethacrylate (GMMA).
• Hydrophobic monomers and oligomers including, for example, bis(glycidyl methacrylate) (bis-GMA), tri(ethyleneglycol) dimethacrylate (TEGDMA), and urethane dimethacrylate may also be utilized.
• Suitable polymerizable polymers include, for example, partially or fully acrylate- or methacrylate-functionalized polymers including, for example, functionalized poly(acrylic acid) polymers, cellulosics, poly(vinylalcohol) polymers, poly(oxyethylene)-poly(oxypropylene) block copolymers, poly(ethyleneglycol) polymers, and the like.
• Chemically Polymerizable Compositions may include glass ionomer cements such as conventional glass ionomer cements that typically employ as their main ingredients a homopolymer or copolymer of an ethylenically unsaturated carboxylic acid (e.g., poly acrylic acid, copoly (acrylic, itaconic acid), and the like), a fluoroaluminosilicate ("FAS") glass, water, and a chelating agent such as tartaric acid.
• Conventional glass ionomers i.e., glass ionomer cements
• Conventional glass ionomers typically are supplied in powder/liquid formulations that are mixed just before use.
• the mixture will undergo self-hardening in the dark due to an ionic reaction between the acidic repeating units of the polycarboxylic acid and cations leached from the glass.
• the glass ionomer cements may also include resin-modified glass ionomer ("RMGI") cements.
• RMGI resin-modified glass ionomer
• Exemplary chemically polymerizable compositions are described, for example, in Applicants' Assignees' copending Application Serial No. 10/327,411, filed December 20, 2002.
• the chemically polymerizable compositions may include redox cure systems that include a polymerizable component (e.g., an ethylenically unsaturated polymerizable component) and redox agents.
• the redox agents may include an oxidizing agent and a reducing agent.
• Suitable polymerizable components, redox agents, optional acid-functional components, and optional fillers that are useful in the present invention are described Applicants' Assignees' copending Application Serial Nos. 10/121,326 and 10/121,329, both filed April 12, 2002.
• the redox agents may include a free-radical initiator system containing enzymes as disclosed in Applicants' Assignees' copending Application Serial No. 10/327,202, filed December 20, 2002.
• the reducing and oxidizing agents should react with or otherwise cooperate with one another to produce free-radicals capable of initiating polymerization of the resin system (e.g., the ethylenically unsaturated component).
• This type of cure is a dark reaction, that is, it is not dependent on the presence of light and can proceed in the absence of light.
• the reducing and oxidizing agents are preferably sufficiently shelf-stable and free of undesirable colorization to permit their storage and use under typical dental conditions. They should be sufficiently compatible with the composition (and preferably water- miscible) to permit ready dissolution in (and discourage separation from) the other components of the polymerizable composition.
• Useful reducing agents include ascorbic acid, ascorbic acid derivatives, and metal complexed ascorbic acid compounds as described in U.S. Pat. No. 5,501,727 (Wang et al.); amines, especially tertiary amines, such as 4-tert-butyl dimethylaniline; aromatic sulfinic salts, such as p-toluenesulfinic salts and benzenesulfinic salts; thioureas, such as l-ethyl-2 -thiourea, tetraethyl thiourea, tetramethyl thiourea, 1,1-dibutyl thiourea, and 1,3-dibutyl thiourea; and mixtures thereof.
• secondary reducing agents may include cobalt (II) chloride, ferrous chloride, ferrous sulfate, hydrazine, hydroxylamine (depending on the choice of oxidizing agent), salts of a dithionite or sulfite anion, and mixtures thereof.
• the reducing agent is an amine.
• Suitable oxidizing agents will also be familiar to those skilled in the art, and include but are not limited to persulfuric acid and salts thereof, such as sodium, potassium, ammonium, cesium, and alkyl ammonium salts.
• Additional oxidizing agents include peroxides such as benzoyl peroxides, hydroperoxides such as cumyl hydroperoxide, t-butyl hydroperoxide, and amyl hydroperoxide, as well as salts of transition metals such as cobalt (III) chloride and ferric chloride, cerium (IN) sulfate, perboric acid and salts thereof, permanganic acid and salts thereof, perphosphoric acid and salts thereof, and mixtures thereof.
• peroxides such as benzoyl peroxides, hydroperoxides such as cumyl hydroperoxide, t-butyl hydroperoxide, and amyl hydroperoxide
• transition metals such as cobalt (III) chloride and ferric chloride, cerium (IN) sulfate, perboric acid and salts thereof, permanganic acid and salts thereof, perphosphoric acid and salts thereof, and mixtures thereof.
• oxidizing agent it may be desirable to use more than one oxidizing agent or more than one reducing agent. Small quantities of transition metal compounds may also be added to accelerate the rate of redox cure. In some embodiments it may be preferred to include a secondary ionic salt to enhance the stability of the polymerizable composition as described in Applicants' Assignees' copending Application Serial No. 10/121,329, filed April 12, 2002.
• the reducing and oxidizing agents are present in amounts sufficient to permit an adequate free-radical reaction rate. This can be evaluated by combining all of the ingredients of the polymerizable composition except for any optional filler, and observing whether or not a hardened mass is obtained.
• the reducing or oxidizing agents can be microencapsulated as described in U.S. Pat. No. 5,154,762 (Mitra et al.). This will generally enhance shelf stability of the polymerizable composition, and if necessary permit packaging the reducing and oxidizing agents together. For example, through appropriate selection of an encapsulant, the oxidizing and reducing agents can be combined with an acid-functional component and optional filler and kept in a storage- stable state.
• the reducing and oxidizing agents can be combined with an FAS glass and water and maintained in a storage-stable state.
• a redox cure system can be combined with other cure systems, e.g., with a glass ionomer cement and with a photopolymerizable composition such as described U.S. Pat. No. 5,154,762 (Mitra et al.).
• the hardenable compositions that utilize a redox cure system can be supplied in a variety of forms including two-part powder/liquid, paste/liquid, and paste/paste systems.
• Other forms employing multi-part combinations i.e., combinations of two or more parts), each of which is in the form of a powder, liquid, gel, or paste are also possible.
• one part typically contains the reducing agent(s) and another part typically contains the oxidizing agent(s). Therefore, if the reducing agent is present in one part of the system, then the oxidizing agent is typically present in another part of the system.
• the reducing agent and oxidizing agent can be combined in the same part of the system through the use of the microencapsulation technique.
• compositions of the present invention include, or may optionally include, additives (e.g., medical additives for medical compositions that are suitable for use in or on the body, dental additives for dental compositions that are suitable for use in the oral environment).
• additives e.g., medical additives for medical compositions that are suitable for use in or on the body, dental additives for dental compositions that are suitable for use in the oral environment.
• Exemplary additives include, for example, fluoride sources, whitening agents, anticaries agents (e.g., xylitol), reminerahzing agents (e.g., calcium phosphate compounds), enzymes, breath fresheners, anesthetics, clotting agents, acid neutralizers, chemotherapeutic agents, immune response modifiers, medicaments, indicators, dyes, pigments, wetting agents, surfactants, buffering agents, viscosity modifiers, thixotropes, fillers, polyols, antimicrobial agents, antifungal agents, stabilizers, agents for treating xerostomia, desensitizers, and combinations thereof.
• the additives are dental additives suitable for use in the oral environment.
• dental whitening compositions generally include a whitening agent.
• the whitening agent used in the present invention may be any material that has the effect of whitening teeth.
• Useful whitening agents include, for example, hypochlorites (e.g., sodium hypochlorite), peroxides, hydroperoxides, hydrogen peroxide, peracids (also known as peroxyacids), carbamide peroxide (i.e., the urea complex of hydrogen peroxide, CO(NH ) 2 H 2 O 2 , also known as urea hydrogen peroxide, hydrogen peroxide carbamide, or perhydrol-urea), and combinations thereof.
• the concentration of a whitening agent in the composition can vary depending upon its activity.
• Compositions of the present invention may be adjusted as desired to include the amount of additive as desired for the specific application.
• compositions of the present invention may also include non- polymerizable polymers.
• the non-polymerizable polymers are partially or fully miscible in an aqueous environment and include, for example, poly(acrylic acid) polymers, cellulosics, poly(vinylalcohol) polymers, poly(oxyethylene)-poly(oxypropylene) block copolymers, poly(ethyleneglycol) polymers, and combinations thereof.
• the treated surface is the surface (e.g., soft or hard tissue) of a body (e.g., animal or human).
• Hard tissues include, for example, bone, teeth, and the component parts of teeth (e.g., enamel, dentin, and cementum).
• Soft tissues include, for example, mucosa (e.g., tongue, gingiva, and throat).
• the treated surface may be, for example, a substrate (e.g., a flexible film).
• a substrate e.g., a flexible film
• the surface-treated substrate may be shaped or deformed. More preferably, the surface-treated substrate may be shaped or deformed by pressure from the surface of a body (e.g., a hand, a foot, a tooth). If only one surface of the substrate is treated, the pressure may be applied from either side of the substrate.
• Compositions of the present invention may be delivered to the desired site by any method as desired. For example, the composition may be delivered directly onto the target site from a container or dispenser. Suitable containers or dispensers include, for example, bottles, vials, syringes, and tubes.
• the composition can be delivered by using a brush, sponge, applicator, or swab to paint or coat the composition onto the target site.
• the compositions may be delivered via spray or aerosol dispensers or by simply rinsing the entire target area (e.g., the oral cavity) with the liquid.
• Another alternative mode of delivery includes the use of a tray type dispenser.
• the composition can be applied to a substrate, and the substrate having the composition thereon can be applied to the desired surface.
• Suitable substrates include, for example, polymeric films, paper, and woven and non-woven sheets.
• the composition can also be applied to a brush, spatula, medical/dental instrument, or an applicator prior to application to the desired surface.
• thermally responsive compositions of the present invention include two or more parts
• the two or more parts are preferably mixed just prior to or during the application process.
• Suitable mixing devices include, for example, static mixing devices.
• the composition is preferably allowed to stand on the surface of the target site long enough to provide the desired effect.
• the standing time will vary depending on the particular composition employed, the type of target site (e.g., tissue), the intended use, and the time available for carrying out the procedure.
• the composition may be allowed to remain on the target site for an extended period of time.
• thermally reversible compositions of the present invention can be readily removed from the target site by cooling the material below the liquid to semi-solid transition temperature, thus reversing the thickening effect. This can be accomplished with cool water or other physiologically compatible liquids.
• the concentrations of the components in the composition may be adjusted and diluted by adding water or other liquids.
• the transition temperature is correspondingly adjusted, and thus provides the user the ability to remove the composition even with warm solutions.
• Water or other liquids may be administered through a rinsing cup, squirt bottle, a liquid dispensing dental tool, or any other liquid dispensing device that can provide a liquid to the oral environment.
• administering cool or cold water provides a significant decrease in viscosity.
• the composition may be brushed, wiped, or blown off.
• Compositions of the present invention that include a reactive polymer may be hardened by inducing the reactive polymer to react.
• composition includes an optional polymerizable component different than the reactive polymer
• hardening of the composition may also include polymerization of the polymerizable component.
• the reactive polymer or the polymerizable component includes an ethylenically unsaturated group
• polymerization may be induced by the application of actinic radiation.
• the composition is irradiated with radiation having a wavelength of 400 to 1200 nanometers, and more preferably with visible radiation.
• Visible light sources include, for example, the sun, lasers, metal vapor (e.g., sodium and mercury) lamps, incandescent lamps, halogen lamps, mercury arc lamps, fluorescent room light, flashlights, light emitting diodes, tungsten halogen lamps, and xenon flash lamps.
• metal vapor e.g., sodium and mercury
• incandescent lamps e.g., sodium and mercury
• halogen lamps e.g., mercury arc lamps
• fluorescent room light e.g., flashlights, light emitting diodes, tungsten halogen lamps, and xenon flash lamps.
• the composition may include two or more parts, with one part including an oxidizing agent, and another part including a reducing agent.
• treatment temperature e.g., a temperature at or near oral temperature
• the viscosity of the composition can increase to thicken the composition.
• a viscosity increase in the range of 10-fold, 50-fold, or even 100-fold or more can be experienced when the initial viscosity is such that the composition is a liquid.
• the thermally responsive composition may separate into phases, resulting, for example, in the formation of a precipitate or a film.
• the film or precipitate is insoluble.
• the substantial moisture content of the composition provides the ability to easily deliver or apply, for example, a gel-on-contact aqueous material that provides substantial hydration of tissues that are subject to dehydration.
• Compositions of the present invention may also be useful for applications including, for example, tissue adhesives and sealants for surgical and medical applications; treatment of periodontal disease; caries reduction gels; oral coatings (with/without local anesthetics) for hard and soft tissues; and dermal and sub-dermal delivery of drugs.
• Polymer A Preparation ofPoly(NIPAAM(76)/HEMA(16)/AAM(8))
• NIPAAM (10 parts), HEMA (1.0 parts), AAM (1.0 parts), VAZO-67 (0.22 parts), and THF (25 parts) were combined in a reaction bottle and the resulting mixture purged with nitrogen for 2 minutes.
• the bottle was sealed and maintained at 60°C in a constant temperature rotating device for 17 hours.
• the resulting viscous polymer solution was poured into a large excess (approximately 5 times volume of reaction mixture) of cyclohexane and the precipitated solid collected by filtration and dried in a 30°C vacuum oven.
• the dried powdery solid was designated Polymer A and identified as the polymer of NIPAAM (76), HEMA (16), and AAM (8) with weight ratios indicated in parentheses.
• Polymers B - E were prepared as described for Polymer A and are listed as follows with monomeric units and weight ratios indicated: Polymer B: NTPAAM(93.3)/AAM(6.5)
• Polymer C NIPAAM(76.9)/AAM(7.7)/NDMA(15.4)
• Polymer D ⁇ IPAAM(83.3)/ ⁇ EMA(16.7)
• Polymer E NIPAAM(76.9)/NDMA(23.1)
• Polymers F and G were prepared as described for Polymer A, except that 3-mercaptopropionic acid (Sigma-Aldrich) was used as a chain transfer agent (0.62 parts), tert-butanol was used as a solvent, and the polymer was precipitated in hexane.
• Polymers F and G are listed as follows with monomeric units and weight ratios indicated:
• Polymer F HO 2 CCH 2 CH 2 CH 2 S-( ⁇ IPAAM(71.5)/HEMA(28.5))
• Polymer G HO 2 CCH 2 CH 2 CH 2 S-(NIPAAM(76.9)/HEMA(15.5)/AAM (7.6))
• SM-1 Synthesis of Trimethylammoniumethyl Methacrylate Tetrafluoroborate (TMA-BF 4 )
• Polymer G (5 parts) was dissolved in THF (10 parts) in a reaction vessel to form a clear solution to which was added DBU (0.04 parts) and then VDMA (0.44 parts). The resulting reaction mixture was stirred and heated at 40°C for 1 hour. The resulting polymer solution was poured into a large excess of cyclohexane (approximately 5 times volume of reaction mixture) and the precipitated solid collected by filtration and dried in a 30°C vacuum oven. The dried solid was designated Example 5 and identified as the Polymer of MPA- (NIP AAM/HEMA/AAM) with a plurality of the HEMA monomeric units and the MPA moiety derivatized with VDMA.
• NIP AAM/HEMA/AAM N-AAM
• Examples 1-3 in individual vials (5 parts each) were combined with chilled (5°C) water (20 parts) and thoroughly mixed at 5°C until either a clear solution or a homogeneous dispersion was obtained.
• the resulting compositions were designated Samples 7a, 7b, and 7c, respectively.
• This composition was designated Sample 8a and, like Sample 7b above, was a fluid and flowable white dispersion at 5°C and 22°C and a cohesive solid gel when heated for 30 seconds at 37°C.
• the composition could be reversibly converted to a liquid dispersion or to a cohesive solid gel upon cooling or heating, respectively.
• Sample 8a in gel form at 37°C in a glass vial was irradiated for 60 seconds with a FX 3000 dental curing light (3M ESPE, St. Paul, MN) by placing the tip of the light guide in direct contact with the vial and rotating the vial throughout the duration of the light exposure.
• the gelled sample was then cooled to 5°C for 5 minutes and observed to be a rubbery solid.
• the sample was no longer thermoreversible and the experiment demonstrated that an irreversible cross-linked hydrogel could be obtained by photopolymerization.
• Sample 9a was irradiated at 37°C in a glass vial by the procedure described in Example 8. Another vial of Sample 9a was irradiated in the same manner at 22°C. Following irradiation at both temperatures, the compositions transformed into rubbery solids that did not exhibit a significant change in appearance when cooled or heated between 5°C and 22°C. The compositions remained as rubbery solids and did not exhibit thermoreversible behavior.
• the resulting polymer solution was designated Example 10 and identified as the polymer of AA (40), ITA (20), NIPAAM (20), and TMA- BF 4 (20) with weight ratios indicated in parentheses.
• the polymer solution was determined to have 18.4%> solids.
• Example 11 AA(40)/ITA(20)/NTPAAM(20)/TMA-BF 4 (18)/LA(2); 21.7% Solids
• Example 12 AA(40)/ITA(20)/NIPAAM(20)/TMA-BF 4 (18)/SiMac(2); 19.2% Solids
• Example 13 AA(40)/ITA(20)/NIPAAM(20)/TMA-BF 4 (18)/ODA(2); 18.8%
• Example 15 polymer solution was made in a 1:1 THF-Ethanol solvent and no water was added after polymerization.
• EXAMPLE 18 Preparation ofPoly(AA(40)/ITA(20)/NIPAAM(20)/TMA-BF 4 (18)/SiMac(2)) in Water AA (40 parts), ITA (20 parts), NIPAAM (20 parts), TMA-BF 4 (18 parts), SiMac (2 parts), V-50 (1 part), and DI water (300 parts) were combined in a reaction vessel and the resulting mixture purged with nitrogen for 5 minutes. The vessel was sealed and maintained at 60°C in a constant temperature rotating device for 30 hours.
• Example 9 Upon cooling to room temperature a viscous polymer solution was obtained that was designated Example 9 and identified as the polymer of AA (40), ITA (20), NIPAAM (20), TMA-BF 4 (18), and SiMac (2 parts) with weight ratios indicated in parentheses. The polymer solution was determined to have 20.0% solids.
• Example 19-21 Preparation ofNIPAAM-Containing Polymers in Water Polymer solutions designated Examples 19-21 were prepared as described for Example 18 and are listed as follows with monomeric units, weight ratios, and % Solids indicated: Example 19: AA(40)/ITA(20)/NIPAAM(20)/TMA-BF 4 (14)/DMA-
• Examples 23 and 24 were prepared in a similar manner and are listed below.
• Example 24 AA(40)/ITA(20)/NIPAAM(20)/MeFBSEMA(5)TMA- BF 4 (15)/ ⁇ IEM; 21.8% Solids EXAMPLES 25-32 Preparation ofPoly(NIPAAM(55)/AA(20)/IBMA(20)/LA(5)) in Isopropanol NIPAAM (55 parts), AA (20 parts), IBMA (20 parts), LA (5 parts), VAZO-67 (1.0 part), and isopropanol (200 parts) were combined in a reaction vessel and the resulting mixture purged with nitrogen for 2 minutes. The vessel was sealed and maintained at 65°C in a constant temperature rotating device for 18 hours during which time a clear viscous polymer solution formed.
• Example 25 A second charge of VAZO-67 (0.20 parts) was added to the reaction vessel and the solution heated at 65°C for an additional 8 hours. After cooling to room temperature, the resulting polymer solution was poured into a large excess of ethyl acetate and the precipitated solid polymer collected by filtration. The solid was washed two times with ethyl acetate and dried in a vacuum oven at 40°C. The dried solid was designated Example 25 and identified as the polymer of NIPAAM (55), AA (20), IBMA (20), and LA (5) with weight ratios indicated in parentheses.
• Example 26 Dried polymers designated Examples 26-32 were prepared as described for Example 25 and are listed as follows with monomeric units and weight ratios indicated:
• Example 26 NIPAAM(45), AA(20), ITA(10), IBMA(20), LA(5)
• Example 27 NIPAAM(45), AA(30), LBMA(20), SiMac(5)
• Example 28 NIPAAM(35), AA(30), ITA(10), IBMA(25)
• Example 29 NIPAAM(55), AA(20), IBMA(20), SiMac(5)
• Example 30 NIPAAM(20), AA(50), IBMA(25), SiMac(5)
• Example 31 NIPAAM(60), AA(20), IBMA(20)
• Example 32 NIPAAM(55), AA(20), IBMA(20), LA(5)

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Medicinal Chemistry (AREA)
• Epidemiology (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Organic Chemistry (AREA)
• Oral & Maxillofacial Surgery (AREA)
• Polymers & Plastics (AREA)
• Inorganic Chemistry (AREA)
• General Chemical & Material Sciences (AREA)
• Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
• Dental Preparations (AREA)
• Macromonomer-Based Addition Polymer (AREA)
• Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
• Compositions Of Macromolecular Compounds (AREA)
• Polyamides (AREA)

Priority Applications (4)

Applications Claiming Priority (4)

Publications (1)

Family

ID=32853361

Family Applications (1)

Country Status (7)

Cited By (3)

Families Citing this family (27)

Citations (2)

Family Cites Families (76)

• 2003
  • 2003-07-24 US US10/626,341 patent/US7223826B2/en not_active Expired - Fee Related
  • 2003-12-17 AU AU2003297243A patent/AU2003297243A1/en not_active Abandoned
  • 2003-12-17 AT AT03815777T patent/ATE399802T1/de not_active IP Right Cessation
  • 2003-12-17 EP EP03815777A patent/EP1587846B1/en not_active Expired - Lifetime
  • 2003-12-17 WO PCT/US2003/040170 patent/WO2004069886A1/en not_active Ceased
  • 2003-12-17 JP JP2004568031A patent/JP5202790B2/ja not_active Expired - Fee Related
  • 2003-12-17 DE DE60321965T patent/DE60321965D1/de not_active Expired - Lifetime

Patent Citations (2)

Also Published As

Similar Documents

Legal Events